The PhRMA Foundation on Monday, Feb. 11, announced plans to fund two new national Centers of Excellence at Tufts Medical Center and the University of Colorado.
PhRMA’s pledge of $500,000 for each center comes as part of its Value Assessment Initiative, according to a press release, which aims “to develop transformative, multi-stakeholder-driven solutions that address challenges in assessing the value of medicines and health care services and ultimately improve patient outcomes and reduce inefficiency.”
According to the release, Tufts’ Center for Enhanced Value Assessment (CEVA) will be led by Peter Neumann, while the University of Colorado’s Center for Pharmaceutical Value will be directed by Jonathan Campbell.
“We welcome CEVA and PValue to our network of Value Assessment Centers of Excellence,” PhRMA Foundation President Eileen Cannon said in a statement. “By advancing important new innovations in cost-effectiveness analysis, these two new research centers will directly benefit patients and families, while moving us … toward a truly value-driven health care system.”
To learn more about the new centers, read the full press release here.